Table 1- B.
SARS CoV-2 positive cases features
| Features | |
|---|---|
| Gestational age at infection diagnosis (wks) | 37.6 ± 4.1 |
| Gestational age at delivery (wks) | 38.9 ± 1.2 |
| Cord pH | 7.32 ± 0.09 |
| Cord pO₂ (mmHg) | 33.24 ± 14.83 |
| SARS-CoV-2 infection course | |
| Asymptomatic | 35 (54.7%) |
| Mild | 14 (21.9%) |
| Moderate | 12 (18.7%) |
| Severe | 3 (4.7%) |
| Oxygen therapy | |
| None | 49 (76.6%) |
| Nasal cannulae | 2 (3.1%) |
| Venturi mask | 2 (3.1%) |
| Pharmacologic therapy | |
| None | 23 (35.9%) |
| Antivirals+Chloroquine+LMWH | 8 (12.5%) |
| Antibiotics added | 11 (17.2%) |
| Only LMWH | 6 (9.4%) |
| Only antibiotics | 9 (14.1%) |
| PCR positive placentas | 7 (14.9%) |
Continuous variables are expressed as mean ± standard deviation (SD). All the other features are expressed as categorical variables in frequencies and their percentages in the brackets.